RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 86 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $35 | -99.9% | 200,190 | +55.7% | 0.00% | – |
| Q3 2022 | $56,000 | -92.0% | 128,590 | -84.4% | 0.00% | -100.0% |
| Q2 2022 | $703,000 | +10.7% | 826,458 | +617.0% | 0.00% | 0.0% |
| Q1 2022 | $635,000 | -7.6% | 115,268 | +62.5% | 0.00% | 0.0% |
| Q4 2021 | $687,000 | +87.2% | 70,954 | +246.1% | 0.00% | – |
| Q3 2021 | $367,000 | -78.0% | 20,500 | -67.5% | 0.00% | -100.0% |
| Q1 2021 | $1,670,000 | +15.2% | 63,000 | -67.0% | 0.00% | 0.0% |
| Q4 2020 | $1,450,000 | +9.4% | 190,989 | -27.9% | 0.00% | +100.0% |
| Q3 2020 | $1,326,000 | +42.6% | 264,728 | +70.2% | 0.00% | 0.0% |
| Q2 2020 | $930,000 | – | 155,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 38,296,526 | $290,671,000 | 5.29% |
| HARBOURVEST PARTNERS LLC | 986,878 | $7,490,000 | 2.93% |
| Abbot Financial Management, Inc. | 537,000 | $4,076,000 | 2.35% |
| Artal Group S.A. | 3,778,913 | $28,682,000 | 0.62% |
| HITE Hedge Asset Management LLC | 88,740 | $674,000 | 0.16% |
| Virtus ETF Advisers LLC | 33,793 | $256,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 394,909 | $2,997,000 | 0.03% |
| Baillie Gifford | 4,710,061 | $35,749,000 | 0.02% |
| Caption Management, LLC | 86,000 | $652,000 | 0.02% |
| Blueshift Asset Management, LLC | 14,626 | $111,000 | 0.01% |